Tech Company Financing Transactions

Electra Therapeutics Funding Round

Electra Therapeutics closed a $183 million Series C investment round on 10/22/2025. Investors included EQT Life Sciences, Nextech and Blue Owl Capital.

Transaction Overview

Announced On
10/22/2025
Transaction Type
Venture Equity
Amount
$183,000,000
Round
Series C
Proceeds Purpose
The company intends to use the funds to conduct a global pivotal Phase 2/3 study of ELA026 in secondary hemophagocytic lymphohistiocytosis (sHLH), a hyperinflammatory disease with high mortality and a lack of treatment options.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
681 Gateway Blvd
South San Francisco, CA 94080
USA
Email Address
Overview
Our mastery of SIRP-directed biology is pointing the way toward breakthrough therapies for immunological diseases and cancer
Profile
Electra Therapeutics LinkedIn Company Profile
Social Media
Electra Therapeutics Company Twitter Account
Company News
Electra Therapeutics News
Facebook
Electra Therapeutics on Facebook
YouTube
Electra Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Adam Rosenthal
  Adam Rosenthal LinkedIn Profile  Adam Rosenthal Twitter Account  Adam Rosenthal News  Adam Rosenthal on Facebook


 

 

Browse more venture capital transactions:

Prev: 10/21/2025: APRO Oracle venture capital transaction
Next: 10/22/2025: Acoru venture capital transaction

 

Share this article

 


News on VC Transactions

Our team works diligently to report on all VC transactions involving tech companies. VC transactions on this site are derived from company press releases and news coverage. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary